	Montrium, a provider of cloud-based software solutions for the life sciences, announced its eTMF Connect trial master file solution is being used in a Phase III global post-traumatic stress disorder (PTSD) trial. The Multidisciplinary Association for Psychedelic Studies (MAPS), a non-profit research organization is advancing from its MAPP1, the first study carried out in Phase III, to a global confirmatory MAPP2 study to assess the safety and efficacy of MDMA-assisted psychotherapy for patients with PTSD.